Apexigen
Latest round
- Series C
Last raised
- Mar 2020
Total raised
- $199M
Investors
- 11
About Apexigen
Apexigen, Inc.Founded in 2010 in San Carlos, US, Apexigen, Inc. specializes in immuno-oncology. The company was acquired by Pyxis Oncology, Inc. on May 24, 2023, for USD 16 mn. The CEO, Xiaodong Yang, leads the firm, which has closed 9 deals overall.Apexigen specializes in developing immuno-oncology therapeutics, primarily focusing on antibody-based products. Their lead product targets the immune checkpoint protein PD-1, aiming to activate the immune response against tumors in patients with various cancers.Apexigen's revenue model is based on strategic partnerships for developing and commercializing therapeutics., Apexigen will support the expansion of its clinical pipeline into Phase 2 for select solid tumor types, leveraging its immuno-oncology expertise. Specific new products are currently under development, although no detailed release dates have been disclosed.
Who invested in Apexigen
11 investors across 6 rounds
See all investors in Apexigen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apexigen
Who invested in Apexigen?
Apexigen has 11 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apexigen raised?
Apexigen has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Apexigen last raise money?
Apexigen's most recent round on record is a Series C, in Mar 2020.
What does Apexigen do?
Apexigen is a biotechnology company.
Where is Apexigen headquartered?
Apexigen is headquartered in San Carlos, US.
Which VCs invest in companies like Apexigen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Apexigen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Apexigen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.